Approvals/TGA/SALPLUSF DPI 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler

Approved

STANDARD

SALPLUSF DPI 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: eb4bc652dd5559a5
Product Name: SALPLUSF DPI 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Artg Id: 418491
Artg Name: SALPLUSF DPI 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2024-01-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f2c30670c786df6d7ec9c99f1736950a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6f1afc93c12ee248635d98294f03a8f8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

eb4bc652dd5559a5

Type

Standard